Sasaki Miho, Sasaki Kenji
Department of Clinical Laboratory, Kanagawa Prefectural Atsugi Hospital, Atsugi 243-0004.
Rinsho Byori. 2002 Jul;50(7):717-20.
We are using infectious disease test kits consisting of positive serum diluted with negative pooled serum (P-S) and positive control (P-C). In two anti-HIV antibody tests the results for both P-S and P-C fluctuated between positive and negative depending on the lot No. of the reagent. In Western blot tests carried out to confirm the tests, the P-C was found to be positive and the P-S tests were both inconclusive. We speculated that the P-S had very weak antibodies that reacted differently from patient samples. Manufacturers of such kits, however, must supply reagents with appropriate reactivity, so it is important that they be informed of inconsistencies that could invalidate cut-off values and lead to false-positives and false-negatives.
我们正在使用由用阴性混合血清稀释的阳性血清(P-S)和阳性对照(P-C)组成的传染病检测试剂盒。在两项抗HIV抗体检测中,P-S和P-C的结果根据试剂的批次号在阳性和阴性之间波动。在为确认检测而进行的蛋白质印迹检测中,发现P-C呈阳性,而P-S检测均无定论。我们推测P-S具有非常弱的抗体,其反应与患者样本不同。然而,此类试剂盒的制造商必须提供具有适当反应性的试剂,因此告知他们可能使临界值无效并导致假阳性和假阴性的不一致情况非常重要。